SARS-CoV-2 in breast milk can be inactivated using Holder pasteurization

Researchers in Germany have shown that human milk infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be pasteurized using a standard method to ensure it is safe for breastfeeding.

Holder pasteurization, which involves heating the milk at 62.5°C for 30 minutes, is an internationally recommended and widely used technique in human milk banks.

SARS-CoV-2 has recently been detected in the milk of infected mothers, prompting concerns about the safety of continuing to breastfeed post-infection.

Now, researchers from Ruhr University Bochum, Ulm University Medical Center, and various other institutions in Germany have shown that Holder pasteurization provides a safe option for infected mothers who want their infants to continue benefiting from breastfeeding.

A pre-print version of the paper is available in the server bioRxiv*, while the article undergoes peer review.

Image Credit: comzeal images / Shutterstock
Image Credit: comzeal images / Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Concerns about mothers infected with SARS-CoV-2

The coronavirus disease 2019 (COVID-19) pandemic has sparked serious concerns about the risks associated with SARS-CoV-2 infection among pregnant or breastfeeding women.

Initially, researchers reported no detection of SARS-CoV-2 in the breast milk of infected mothers, and the risk for vertical (mother-to-baby) transmission was considered very low.

However, Stephanie Pfaender and colleagues, as well as other research groups, have recently reported detecting SARS-CoV-2 RNA in breast milk samples taken from mothers with COVID-19.

In two cases where mothers continued to breastfeed, the infants also tested positive for the virus, and in one case, a baby developed severe respiratory disease.

Although the source of infection among the newborns is unclear, the findings raise concerns about potential transmission to infants via breast milk, say Pfaender and team.

These concerns are particularly important to address since breastmilk contains various nutrients, hormones, and immune system components that significantly benefit developing newborns. Breastfeeding is widely recommended as the optimal method for feeding babies.

Mothers with SARS-CoV-2 are currently advised to continue breastfeeding

Currently, the World Health Organization advises infected mothers to continue breastfeeding, while following strict hygiene measures such as wearing masks to shield infants from exposure to infected droplets or aerosols.

The Centers for Disease Control and Prevention says the decision over whether to continue breastfeeding lies with the mother and her family and healthcare provider, although mothers are generally advised to continue.

However, since the virus has recently been detected in maternal breast milk, the possibility of vertical transmission cannot be overlooked, and safety measures to protect infants are urgently needed, say Pfaender and team.

Testing whether Holder pasteurization can make the milk safe

Now, the team has tested whether SARS-CoV-2 present in breast milk can be inactivated using Holder pasteurization to minimize the risk of transmission, while still maintaining the milk’s many beneficial, protective properties.

“Here, we evaluated holder pasteurization as an easy and inexpensive method to inactivate infectious SARS-CoV-2 in breast milk,” writes the team.

Five different isolates of SARS-CoV-2 were introduced to five different breast milk samples, which were then incubated for 30 minutes, either at room temperature or at 63°C.

On testing the samples for residual infectivity, the researchers found that all five SARS-CoV-2 isolates were still infective in all samples that had been incubated at room temperature.

However, none of the samples subjected to Holder pasteurization showed any residual infectivity.

“Viral infectivity is completely eliminated by this treatment”

“Our data show that independent of the tested SARS-CoV-2 isolates or the breast milk sample, viral infectivity is eliminated completely by this treatment,” say Pfaender and team. “Thus, human breast milk containing infectious SARS-CoV-2 can be efficiently inactivated using standard holder pasteurization.”

The researchers say their study shows that infected mothers who still want to breastfeed rather than use formula milk can be reassured that Holder pasteurization is a safe way to proceed.

“We here provide a safe and feasible option, when in doubt, to continue feeding of the infant with breast milk upon symptomatic SARS-CoV-2 infection of the mother,” the team concludes.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Mar 22 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2023, March 22). SARS-CoV-2 in breast milk can be inactivated using Holder pasteurization. News-Medical. Retrieved on December 19, 2024 from https://www.news-medical.net/news/20200618/SARS-CoV-2-in-breast-milk-can-be-inactivated-using-Holder-pasteurization.aspx.

  • MLA

    Robertson, Sally. "SARS-CoV-2 in breast milk can be inactivated using Holder pasteurization". News-Medical. 19 December 2024. <https://www.news-medical.net/news/20200618/SARS-CoV-2-in-breast-milk-can-be-inactivated-using-Holder-pasteurization.aspx>.

  • Chicago

    Robertson, Sally. "SARS-CoV-2 in breast milk can be inactivated using Holder pasteurization". News-Medical. https://www.news-medical.net/news/20200618/SARS-CoV-2-in-breast-milk-can-be-inactivated-using-Holder-pasteurization.aspx. (accessed December 19, 2024).

  • Harvard

    Robertson, Sally. 2023. SARS-CoV-2 in breast milk can be inactivated using Holder pasteurization. News-Medical, viewed 19 December 2024, https://www.news-medical.net/news/20200618/SARS-CoV-2-in-breast-milk-can-be-inactivated-using-Holder-pasteurization.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Futuristic AI-powered virtual lab designs potent SARS-CoV-2 nanobodies